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Book Reviews
Prediction of Response in Cancer
Therapy. Edit. THOMAS C. HALL. U.S.
Department of Health Education and
Welfare Public Health Service, National
Institutes of Health, National Cancer
Institute, Bethesda, Maryland 20014. 298
pages. Price $4.50.
This is National Cancer Institute Mono-
graph No. 34 and it contains the proceedings
of a symposium held at Cascades Conference
Centre, Virginia, in February 1970.
There are 9 panels each containing 2 to 7
papers and an account of the ensuing dis-
cussion. The subjects of the panels are Cell
Kinetics and Therapeutic Response, Hor-
monal Influences, Immunologic Factors,
Genetic Factors, Studies in Leukaemia,
Studies with Solid Tumours, In vivo Histo-
logic Studies, In vivo Predictive Tests and
Clinicoepidemiologic Factors. There are 35
papers by authors who are distinguished in
their fields and the general presentation of
the material is excellent. The greater part
ofthe work presented is from the laboratory,
but most of it has immediate clinical rele-
vance. There are papers referring to radia-
tion treatment and to surgery (especially
" endocrine surgery ") but most of the
monograph is devoted to the drug treatment
of malignant disease with an emphasis on
biochemical aspects and tests. The poten-
tial value of methods of prediction both in
the selection of the most effective treatment
and in the avoidance of ineffective treatment
with its unnecessary drug toxicity, or surgical
hazards, is self evident.
Individual mention cannot be made of all
papers so 4 which share a common theme are
selected. Hilf draws attention to some
similarities between rodent and human
breast cancer which suggest that the former
is a reasonable " model " to use. He then
goes on to demonstrate that glucose-6
phosphate dehydrogenase levels may be high
in tumours which are unresponsive to oestro-
gen, and low in responsive tumours and that
the level rises during treatment. Another
enzyme, a-glycerophosphate dehydrogenase
is found at high levels in normal breast tissue
and in responsive tumours but at low levels
in unresponsive tumours. Jensen and col-
leagues describe the two-stage binding of
oestradiol to protein and its incorporation
into the nucleus, and follow this with a
tentative demonstration that if a breast
tumour lacks oestrogen receptor substance
then it is unlikely to respond to endocrine
therapy. Braunsberg and colleagues using
tritiated steroid show that testosterone is not
concentrated in breast cancer but that
oestrogen is concentrated in some, though
not all. Dao and Libby describe bio-
chemical work on the conjugation of oestra-
diol and dehydroepiandrosterone (D.H.E.A.)
by mammary cancer tissue. They suggest
that with a D.H.E.A. to oestradiol uptake of
greater than unity fewer patients have
metastases and those who do are more likely
to respond to adrenalectomy, but with a
ratio of less than unity metastases are more
common and few regress after adrenalectomy.
The inactive tumours also fail to respond to
adrenalectomy. These 4 papers all seem to
point in the same direction and suggest that
one should be able to select the hormone-
responsive breast cancers on a less empirical
basis than previously.
Each panel is concluded by valuable dis-
cussion which should not be overlooked.
One of the few defects in the presentation is
that many of the papers do not contain
summaries.
This monograph contains many examples
of fruitful cooperation between laboratory
and clinical workers and is strongly recom-
mended to both.
I. D. H. TODD
The Design of Clinical Trials in Cancer
Therapy. Edit. M. STAQUET. Brussels:
Editions Scientifique Europeennes. (F.B.
690.)
This is a report of the proceedings of a
course in clinical pharmacology held at the
Institute Jules Bordet, Brussels in May 1972,
under the auspices of the EORTC.
There are 15 authors from Europe and the
United States all with established reputations
inthis field. Two ofthe papers are in French,
the remainder are in English. The book is
divided into 5 chapters. The first deals with
animal screening and toxicity-it contains 4
papers by Goldin and one by Eckhardt.
The second is about the experimental bases
of the use of chemotherapy in man and is